Literature DB >> 8073453

Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

M A Albanese1, W R Clarke, H P Adams, R F Woolson.   

Abstract

BACKGROUND AND
PURPOSE: Ensuring the reliability and validity of outcome measures used in clinical trials is essential to the success of the trial. The Trial of Org 10172 in Acute Stroke Treatment (TOAST) is a multicenter clinical trial that is recruiting patients with acute ischemic stroke seen at medical centers across the United States.
METHODS: This paper describes an approach to train physicians to use three clinical measures: the National Institutes of Health (NIH) Stroke Scale, a supplemental motor examination, and the Glasgow Outcome Scale. The program included education, certification, remediation when needed, monitoring, and reliability assessment. The goal was to ensure that interrater assessments were as equivalent to one another as possible.
RESULTS: Of the first 95 clinicians who began the certification process, 75 passed during the first evaluation. Eighteen of the other physicians were able to complete the process after remediation. The intraclass correlations of both the NIH Stroke Scale and supplemental motor examination exceeded 0.95. The kappa values for the Glasgow Outcome Scale were 0.61 and 0.62 for the first and second ratings of the videotape, respectively.
CONCLUSIONS: Our experience suggests that a program that includes educational and certification processes can be performed as part of the design of a multicenter clinical trial. The method of providing educational and testing videotapes to each site so that physicians can be trained and certified is an effective, inexpensive, and practical approach for enhancing and certifying the expertise of the large number of physicians involved in a multicenter study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073453     DOI: 10.1161/01.str.25.9.1746

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-21       Impact factor: 2.136

2.  Different risk factor profiles between subtypes of ischemic stroke. A case-control study in Korean men.

Authors:  Yun-Mi Song; Sun Uck Kwon; Joohon Sung; Shah Ebrahim; George Davey Smith; Sung Sunwoo; Yeong Sook Yun
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Pathogenesis of deep white matter medullary infarcts: a diffusion weighted magnetic resonance imaging study.

Authors:  P H Lee; S H Oh; O Y Bang; I S Joo; K Huh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videos.

Authors:  R T F Cheung; P D Lyden; T H Tsoi; Y Huang; M Liu; S F K Hon; R Raman; L Liu
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

5.  Validity and reliability of a korean version of the national institutes of health stroke scale.

Authors:  Mi Sun Oh; Kyung-Ho Yu; Ju-Hun Lee; San Jung; Im-Suck Ko; Joon-Hyun Shin; Soo-Jin Cho; Hui-Chul Choi; Hyang Hee Kim; Byung-Chul Lee
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

6.  Is the NIHSS certification process too lenient?

Authors:  Nancy K Hills; S Andrew Josephson; Patrick D Lyden; S Claiborne Johnston
Journal:  Cerebrovasc Dis       Date:  2009-03-19       Impact factor: 2.762

7.  Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.

Authors:  Uwe Pichlmeier; Andrea Bink; Gabriele Schackert; Walter Stummer
Journal:  Neuro Oncol       Date:  2008-07-30       Impact factor: 12.300

8.  Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.

Authors:  Thomas Hundsberger; Detlef Brügge; Paul M Putora; Patrik Weder; Johannes Weber; Ludwig Plasswilm
Journal:  J Neurooncol       Date:  2013-01-12       Impact factor: 4.130

9.  Preliminary efficacy report of a novel thrombolytic agent for acute ischaemic stroke within a 5-hour window.

Authors:  A-Ching Chao; Michael Mu-Huo Teng; Chih-Ping Chung; Hsing-Yu Weng; Yen-Yu Chen; Fu-Yi Yang; Lee-Min Wang; Han-Hwa Hu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Prestroke factors associated with poststroke mortality and recovery in older women in the Women's Health Initiative.

Authors:  Christina L Bell; Andrea LaCroix; Kamal Masaki; Erinn M Hade; Todd Manini; W Jerry Mysiw; Jess David Curb; Sylvia Wassertheil-Smoller
Journal:  J Am Geriatr Soc       Date:  2013-07-19       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.